{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:52:06Z","timestamp":1793404326490,"version":"4.5.0"},"reference-count":132,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"Principia Biopharma Inc, and Pierre Fabre Dermatologie"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.2217\/imt-2020-0189","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T06:34:16Z","timestamp":1602570856000},"page":"35-53","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Clinical and Biological Activity of Rituximab in the Treatment of Pemphigus"],"prefix":"10.1080","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8792-979X","authenticated-orcid":false,"given":"G\u00e9r\u00f4me","family":"Bohelay","sequence":"first","affiliation":[{"name":"Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, AP-HP&amp;INSERM UMR1125, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Caux","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, AP-HP&amp;INSERM UMR1125, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Musette","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, AP-HP&amp;INSERM UMR1125, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31778-7"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198205203062001"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8748"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13106"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12772"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067752"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2017.05.002"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062930"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.1522"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30070-3"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005166"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh009"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2005.02213.x"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/74704"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2012.02.011"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39167"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200337"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.10.007"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126273"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05209_10.x"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.06.007"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06651.x"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08358.x"},{"issue":"4","key":"e_1_3_5_27_1","first-page":"379","article-title":"Response in patients with pemphigus vulgaris to rituximab therapy. Basis of the biology of B cells","volume":"144","author":"Leuci S","year":"2009","unstructured":"Leuci S , LevineD , ZhangJ , RazzaqueAhmed A. Response in patients with pemphigus vulgaris to rituximab therapy. Basis of the biology of B cells. G. Ital. Dermatol. Venereol.144(4), 379\u2013409 (2009).","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10411.x"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10663.x"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.11.007"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04391.x"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.08.010"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2012.5847.x"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12080"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000357031"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.05.071"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1746"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.6739"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.2421"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.02.013"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.01.029"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5176"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.11.024"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1727440"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16561"},{"key":"e_1_3_5_46_1","first-page":"1","article-title":"Efficacy and safety of biosimilar rituximab in patients with pemphigus vulgaris: a prospective observational study","author":"Toosi R","year":"2019","unstructured":"Toosi R , MahmoudiH , BalighiKet al. Efficacy and safety of biosimilar rituximab in patients with pemphigus vulgaris: a prospective observational study. J. Dermatol. Treat1\u20138 (2019).","journal-title":"J. Dermatol. Treat"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12972"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.12.002"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2116"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12678"},{"key":"e_1_3_5_51_1","first-page":"1","article-title":"Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients","volume":"7","author":"Kianfar N","year":"2020","unstructured":"Kianfar N , DasdarS , MahmoudiHet al. Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients. J. Dermatolog. Treat.7, 1\u20136 (2020).","journal-title":"J. Dermatolog. Treat."},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18482"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.021"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15947"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16752"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13154"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.3674"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.04.031"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.032"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.07.717"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.178"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.291"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.1.361"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10658.x"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.11.012"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181735723"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.6.2257"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93222"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.27"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.172"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01794"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.448"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-013-1355-4"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-585976"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1159\/000099585"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1159\/000448031"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1754-z"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040673"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.05.007"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12299"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2011.02.009"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3908"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12220"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.07.012"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01375"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.002"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.10.051"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.9"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.976629"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12187"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10732.x"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/321950"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2013.838563"},{"issue":"3","key":"e_1_3_5_94_1","first-page":"iii28","article-title":"Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs","volume":"47","author":"\u00d8stensen M","year":"2008","unstructured":"\u00d8stensen M , LockshinM , DoriaAet al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatol.47(Suppl. 3), iii28\u201331 (2008).","journal-title":"Rheumatol."},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15930"},{"issue":"1","key":"e_1_3_5_96_1","first-page":"31","article-title":"Health economic analysis of the burden of infusion reactions on patients, caregivers, and providers","volume":"23","author":"Fortner B","year":"2009","unstructured":"Fortner B , VialePH. Health economic analysis of the burden of infusion reactions on patients, caregivers, and providers. Oncology23(1 Suppl. 2), 31\u201336 (2009).","journal-title":"Oncology"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2014.14092"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13757"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13823"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2020.1717526"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-017-0330-4"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13586"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2018.3373"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2808"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.892635"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12860"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.10.015"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1429"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1086\/345746"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/945950"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13302"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i7.954"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.140301"},{"issue":"6","key":"e_1_3_5_114_1","doi-asserted-by":"crossref","first-page":"13030\/qt8927s9k","DOI":"10.5070\/D3236035399","article-title":"Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection","volume":"23","author":"Tavakolpour S","year":"2017","unstructured":"Tavakolpour S , SooriT , NoormohammadpourP , BalighiK , MahmoudiH , DaneshpazhoohM. Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection. Dermatol. Online J.23(6), 13030\/qt8927s9kt (2017).","journal-title":"Dermatol. Online J."},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13990"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2077"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.036"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.05.076"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13400"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-1"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09204.x"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13330"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12793"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.06.009"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.005"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.05.034"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.1939"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex067"},{"key":"e_1_3_5_129_1","article-title":"A randomized, partial-blind, placebo-controlled trial evaluating the efficacy, safety, pharmacokinetics and pharmacodynamics of VAY736 in the treatment of patients with pemphigus vulgaris","author":"Novartis Pharmaceuticals","year":"2020","unstructured":"Novartis Pharmaceuticals . A randomized, partial-blind, placebo-controlled trial evaluating the efficacy, safety, pharmacokinetics and pharmacodynamics of VAY736 in the treatment of patients with pemphigus vulgaris. Clinicaltrials.gov; 2019. Report No.: NCT01930175. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01930175","journal-title":"Clinicaltrials.gov; 2019. Report No.: NCT01930175."},{"key":"e_1_3_5_130_1","article-title":"A randomized, double-blind, placebo-controlled, multicenter trial to evaluate the efficacy and safety of oral BTK inhibitor PRN1008 in moderate to severe pemphigus","author":"Principia Biopharma Inc","year":"2020","unstructured":"Principia Biopharma Inc . A randomized, double-blind, placebo-controlled, multicenter trial to evaluate the efficacy and safety of oral BTK inhibitor PRN1008 in moderate to severe pemphigus. Clinicaltrials.gov; 2020. Report No.: NCT03762265. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03762265","journal-title":"Clinicaltrials.gov; 2020. Report No.: NCT03762265."},{"key":"e_1_3_5_131_1","article-title":"A Phase I, open-label, safety and dosing study of autologous desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in subjects with active, anti-DSG3, mucosal-dominant pemphigus vulgaris","author":"Cabaletta Bio","year":"2020","unstructured":"Cabaletta Bio . A Phase I, open-label, safety and dosing study of autologous desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in subjects with active, anti-DSG3, mucosal-dominant pemphigus vulgaris. Clinicaltrials.gov; 2020. Report No.: NCT04422912. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04422912","journal-title":"Clinicaltrials.gov; 2020. Report No.: NCT04422912."},{"key":"e_1_3_5_132_1","article-title":"A Phase IB\/II, multicenter, open-label, safety, and dose-finding study of SYNT001 in subjects with pemphigus (vulgaris or foliaceus)","author":"Alexion Pharmaceuticals","year":"2020","unstructured":"Alexion Pharmaceuticals . A Phase IB\/II, multicenter, open-label, safety, and dose-finding study of SYNT001 in subjects with pemphigus (vulgaris or foliaceus). Clinicaltrials.gov. 2020. Report No.: NCT03075904. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03075904","journal-title":"Clinicaltrials.gov. 2020. Report No.: NCT03075904."},{"key":"e_1_3_5_133_1","article-title":"Efgartigimod in pemphigus: interim Phase II results","author":"Goebeler M","year":"2020","unstructured":"Goebeler M , Bata-Cs\u00f6rg\u0151Z , BaumS, Cet al.Efgartigimod in pemphigus: interim Phase II results. Virtual Annual Meeting of the Society of Investigative Dermatology.13\u201316 May, 2020Oral communication #537.","journal-title":"Virtual Annual Meeting of the Society of Investigative Dermatology."},{"key":"e_1_3_5_134_1","article-title":"Polyclonal regulatory T cells (PolyTregs) for pemphigus","author":"National Institute of Allergy and Infectious Diseases (NIAID)","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID) . Polyclonal regulatory T cells (PolyTregs) for pemphigusClinicalTrials.gov. 2020. Report No.: NCT04422912. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03239470","journal-title":"ClinicalTrials.gov. 2020. Report No.: NCT04422912"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2020-0189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:01:16Z","timestamp":1715958076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2020-0189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.2217\/imt-2020-0189"],"URL":"https:\/\/doi.org\/10.2217\/imt-2020-0189","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}